![Ruxolitinib for the treatment of severe alopecia areata - Journal of the American Academy of Dermatology Ruxolitinib for the treatment of severe alopecia areata - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/00589ab0-92fe-40c8-a214-db91cc31d3a9/gr1.jpg)
Ruxolitinib for the treatment of severe alopecia areata - Journal of the American Academy of Dermatology
![Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2041930290/2055311285/gr1.jpg)
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine
![References in Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata - Journal of the American Academy of Dermatology References in Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2097898841/2078472167/gr1.jpg)
References in Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata - Journal of the American Academy of Dermatology
Journal of Clinical Investigation - JCI INSIGHT: JAK inhibitors reverse hair loss in alopecia areata There are few treatments available to prevent and reverse hair loss associated with alopecia areata, a common
![An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis - ScienceDirect An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022202X18301179-gr1.jpg)
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis - ScienceDirect
![JAK inhibitors and alopecia: After positive early data, various trials now underway | MDedge Dermatology JAK inhibitors and alopecia: After positive early data, various trials now underway | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/125408_photo1_web.jpg)
JAK inhibitors and alopecia: After positive early data, various trials now underway | MDedge Dermatology
![Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata Dai YX, Yeh CP, Chen CC - Dermatol Sin Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata Dai YX, Yeh CP, Chen CC - Dermatol Sin](https://www.dermsinica.org/articles/2020/38/1/images/DermatolSin_2020_38_1_3_279598_f1.jpg)
Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata Dai YX, Yeh CP, Chen CC - Dermatol Sin
![JAK inhibitor drugs could restore hair growth after loss from male pattern baldness | NextBigFuture.com JAK inhibitor drugs could restore hair growth after loss from male pattern baldness | NextBigFuture.com](http://3.bp.blogspot.com/-q4-f3V4jtuo/VjUUpjVIUYI/AAAAAAABDxY/LckDsQHjxUc/s1600/reversinghairloss.jpeg)
JAK inhibitor drugs could restore hair growth after loss from male pattern baldness | NextBigFuture.com
![Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients Shivanna CB, Shenoy C, Priya R A - Int J Trichol Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients Shivanna CB, Shenoy C, Priya R A - Int J Trichol](https://www.ijtrichology.com/articles/2018/10/3/images/IntJTrichol_2018_10_3_103_234782_f1.jpg)
Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients Shivanna CB, Shenoy C, Priya R A - Int J Trichol
![Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients - Journal of the American Academy of Dermatology Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2118945531/2087085920/gr1.jpg)
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients - Journal of the American Academy of Dermatology
![Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/79/5/674/F1.large.jpg)
Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases
![Frontiers | Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib | Immunology Frontiers | Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib | Immunology](https://www.frontiersin.org/files/Articles/654376/fimmu-12-654376-HTML-r1/image_m/fimmu-12-654376-g001.jpg)